Home » FDA Approves BioImagene Device
FDA Approves BioImagene Device
Digital pathology company BioImagene Inc. said it received clearance from the Food and Drug Administration for its Pathiam System with iScan for assessment of HER2/neu immunohistochemistry tests.
Silicon Valley/San Jose Business Journal
Silicon Valley/San Jose Business Journal
Upcoming Events
-
07May
-
14May
-
30May